This article is more than 5 years old. Information may no longer be current.

Yale appoints research program leader for head and neck cancers

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Barbara Ann Burtness, MD, has been named clinical research program leader of the head and neck cancers program at Smilow Cancer Hospital at Yale-New Haven and co-director of the developmental therapeutics research program for Yale Cancer Center.

Her appointment will be effective April 1.

 

Barbara A. Burtness

Burtness — a HemOnc Today Editorial Board member — spent the past eight years at Fox Chase Cancer Center, where she served as chief of the Head and Neck Oncology Section, associate director of clinical research and professor of medical oncology. She is chair of ECOG’s Head and Neck Cancer Committee and a member of the NCI Head and Neck Steering Committee.

“Dr. Burtness’ strong patient care and clinical research experience will bring a new level of translational cancer medicine to our head and neck cancers program,” Roy S. Herbst, MD, PhD, chief of medical oncology, Ensign professor of medicine and associate director for clinical research at Yale Cancer Center, said in a press release.  “Her ability to lead our clinical research efforts in head and neck cancers, and continue the strong track record of achievements in developmental therapeutics at Yale Cancer Center, will be a tremendous asset to our success in the coming years.”

Burtness’ research has focused on targeted treatments for EGFR-expressed head and neck cancers. She received her medical degree from the State University of New York at Stony Brook. She completed her internship and residency at Yale-New Haven Hospital, and a fellowship in Hematology/Oncology at Memorial Sloan-Kettering Cancer Center.